University of Leipzig, Heart Center, Department of Internal Medicine/Cardiology, Leipzig, Germany.
Circ Cardiovasc Imaging. 2012 Jan;5(1):119-26. doi: 10.1161/CIRCIMAGING.111.965467. Epub 2011 Oct 25.
There is conflicting evidence regarding sex-based differences in myocardial salvage and clinical outcome in patients after ST-elevation myocardial infarction (STEMI). The aim of this study was to investigate whether there are sex-associated differences in infarct characteristics (myocardial salvage, infarct size, microvascular obstruction) and clinical outcome in STEMI patients who are reperfused by primary angioplasty.
In this study, we included 96 women and 239 men with STEMI undergoing primary angioplasty <12 hours after symptom onset. T2-weighted and contrast-enhanced cardiac MRI was used to assess myocardial salvage, infarct size, and microvascular obstruction. The primary clinical end point was mortality within 6 months after the index event. The amount of myocardium at risk and final infarct size did not differ significantly between women and men. Consequently, myocardial salvage was similar between groups (P=0.36). Women had a higher in-hospital (3% versus 10%; P=0.03) and 30-day (5% versus 11%; P=0.05) mortality rate than did men. Six months after infarction, no significant sex differences in survival were obvious (11% versus 7%; P=0.21). After adjustment for baseline differences (age, diabetes, hypertension), female sex was not an independent predictor of mortality and major adverse cardiac events.
The efficacy of primary percutaneous coronary intervention (myocardial salvage) in patients with STEMI is not sex dependent. Although women STEMI patients had worse unadjusted in-hospital and 30-day clinical outcomes than did men, multivariate analysis revealed that the observed sex-based differences in early death after STEMI were likely related to differences in baseline risk and clinical characteristics.
关于 ST 段抬高型心肌梗死(STEMI)患者的心肌挽救和临床结局是否存在性别差异,目前存在相互矛盾的证据。本研究旨在探讨在接受直接经皮冠状动脉介入治疗(primary angioplasty)的 STEMI 患者中,梗死特征(心肌挽救、梗死面积、微血管阻塞)和临床结局是否存在与性别相关的差异。
本研究纳入了 96 名女性和 239 名男性 STEMI 患者,这些患者在症状发作后 12 小时内接受了 primary angioplasty。使用 T2 加权和对比增强心脏 MRI 评估心肌挽救、梗死面积和微血管阻塞。主要临床终点是指数事件后 6 个月内的死亡率。女性和男性的危险心肌量和最终梗死面积没有显著差异。因此,两组之间的心肌挽救相似(P=0.36)。女性的院内(3%比 10%;P=0.03)和 30 天死亡率(5%比 11%;P=0.05)高于男性。梗死后 6 个月,女性的生存率没有明显的性别差异(11%比 7%;P=0.21)。在调整了基线差异(年龄、糖尿病、高血压)后,女性性别不是死亡率和主要不良心脏事件的独立预测因素。
STEMI 患者直接经皮冠状动脉介入治疗(心肌挽救)的疗效与性别无关。尽管女性 STEMI 患者的未调整院内和 30 天临床结局比男性差,但多变量分析显示,STEMI 后早期死亡的观察到的性别差异可能与基线风险和临床特征的差异有关。